Insight

Photo from The Institute of Cancer Research/LinkedIn

Sep 7, 2024, 15:31

Potential drug to target a rare childhood brain tumour – ICR

The Institute of Cancer Research (ICR) shared a post on LinkedIn:

“News: Research reveals a potential drug to target a rare childhood brain tumour.

ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.

Read more about the research, funded by The Brain Tumour Charity.”

Potential drug to target a rare childhood brain tumour - ICR

Source: The Institute of Cancer Research/LinkedIn

More posts featuring The Institute of Cancer Research on oncodaily.com

cancer childhood brain tumour Dana-Farber Cancer Institute ICR OncoDaily Oncology Ribociclib The Brain Tumour Charity The Institute of Cancer Research

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage